An investigation of protein absorption II : a randomized, double-blind, placebo-controlled, crossover trial.

An investigation of protein absorption II: a randomized, double-blind, placebo-controlled, crossover trial. - An investigation of protein absorption II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000056417

Enrollment

Registered

2024-12-10

Start date

2024-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult people

Interventions

Duration: single dose Test food: active food and placebo food Administration: Eat test food with water during meal I. Eat the prescribed diet with placebo food for breakfast. II. Eat the prescri

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Japanese adult male and female

Exclusion criteria

Exclusion criteria: 1. A medical history of malignant tumor, heart failure or myocardial infarction. 2. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus. 3. Subjects who are allergic to the test food related products.

Design outcomes

Primary

Measure	Time frame
Blood amino acid AUC, Cmax and Tmax. *Collected serum at baseline, 30, 60, 90, 120, and 180 minutes after intake.	—

Countries

Japan

Contacts

Public ContactDaiki Suehiro

San-ei Sucrochemical Co., Ltd. Research and Development Section

daiki-suehiro@sanei-toka.co.jp0562-55-5197

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026